Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 941

1.

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia.

Papaluca T, O'Keefe J, Bowden S, Doyle JS, Stoove M, Hellard M, Thompson AJ.

J Clin Virol. 2019 Oct 3;120:84-87. doi: 10.1016/j.jcv.2019.09.011. [Epub ahead of print]

PMID:
31606586
2.

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.

Scott N, Wilson DP, Thompson AJ, Barnes E, El-Sayed M, Benzaken AS, Drummer HE, Hellard ME.

BMC Med. 2019 Sep 18;17(1):175. doi: 10.1186/s12916-019-1411-9.

3.

Author Correction: Niche stiffness underlies the ageing of central nervous system progenitor cells.

Segel M, Neumann B, Hill MFE, Weber IP, Viscomi C, Zhao C, Young A, Agley CC, Thompson AJ, Gonzalez GA, Sharma A, Holmqvist S, Rowitch DH, Franze K, Franklin RJM, Chalut KJ.

Nature. 2019 Sep;573(7773):E3. doi: 10.1038/s41586-019-1552-1.

PMID:
31462780
4.

Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol.

Basnayake C, Kamm MA, Salzberg M, Khera A, Liew D, Burrell K, Wilson-O'Brien A, Stanley A, Talley NJ, Thompson AJ.

Contemp Clin Trials. 2019 Sep;84:105828. doi: 10.1016/j.cct.2019.105828. Epub 2019 Aug 19.

PMID:
31437539
5.

Niche stiffness underlies the ageing of central nervous system progenitor cells.

Segel M, Neumann B, Hill MFE, Weber IP, Viscomi C, Zhao C, Young A, Agley CC, Thompson AJ, Gonzalez GA, Sharma A, Holmqvist S, Rowitch DH, Franze K, Franklin RJM, Chalut KJ.

Nature. 2019 Sep;573(7772):130-134. doi: 10.1038/s41586-019-1484-9. Epub 2019 Aug 15. Erratum in: Nature. 2019 Aug 29;:.

PMID:
31413369
6.

Delivery of Care for Functional Gastrointestinal Disorders: A Systematic Review.

Basnayake C, Kamm MA, Salzberg MR, Wilson-O'Brien A, Stanley A, Thompson AJ.

J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14830. [Epub ahead of print]

PMID:
31411755
7.

MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers.

Freund P, Seif M, Weiskopf N, Friston K, Fehlings MG, Thompson AJ, Curt A.

Lancet Neurol. 2019 Aug 9. pii: S1474-4422(19)30138-3. doi: 10.1016/S1474-4422(19)30138-3. [Epub ahead of print] Review.

PMID:
31405713
8.

Automatic detection of feeding- and drinking-related agonistic behavior and dominance in dairy cows.

Foris B, Thompson AJ, von Keyserlingk MAG, Melzer N, Weary DM.

J Dairy Sci. 2019 Oct;102(10):9176-9186. doi: 10.3168/jds.2019-16697. Epub 2019 Aug 7.

9.

Clinical Cases in Hepatitis: Towards improving liver disease management in Australia.

Strasser SI, Thompson AJ, Roberts SK, George J; Clinical Cases in Hepatitis 2018 Steering Committee.

J Gastroenterol Hepatol. 2019 Jul;34 Suppl 1:5-15. doi: 10.1111/jgh.14720.

PMID:
31282011
10.

Anesthetics: from modes of action to unconsciousness and neurotoxicity.

Iqbal F, Thompson AJ, Riaz S, Pehar M, Rice T, Syed NI.

J Neurophysiol. 2019 Aug 1;122(2):760-787. doi: 10.1152/jn.00210.2019. Epub 2019 Jun 26.

PMID:
31242059
11.

A challenge finding P2X1 and P2X4 ligands.

Beswick P, Wahab B, Honey MA, Paradowski M, Jiang K, Lochner M, Murrell-Lagnado RD, Thompson AJ.

Neuropharmacology. 2019 Oct;157:107674. doi: 10.1016/j.neuropharm.2019.107674. Epub 2019 Jun 24.

12.

Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs.

Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, Hellard ME.

Clin Infect Dis. 2019 Jun 22. pii: ciz546. doi: 10.1093/cid/ciz546. [Epub ahead of print]

PMID:
31233117
13.

An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells.

Narimatsu Y, Joshi HJ, Nason R, Van Coillie J, Karlsson R, Sun L, Ye Z, Chen YH, Schjoldager KT, Steentoft C, Furukawa S, Bensing BA, Sullam PM, Thompson AJ, Paulson JC, Büll C, Adema GJ, Mandel U, Hansen L, Bennett EP, Varki A, Vakhrushev SY, Yang Z, Clausen H.

Mol Cell. 2019 Jul 25;75(2):394-407.e5. doi: 10.1016/j.molcel.2019.05.017. Epub 2019 Jun 18.

PMID:
31227230
14.

Author Correction: In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor.

Yang YA, Lee S, Zhao J, Thompson AJ, McBride R, Tsogtbaatar B, Paulson JC, Nussinov R, Deng L, Song J.

Nat Microbiol. 2019 Jul;4(7):1242. doi: 10.1038/s41564-019-0505-7.

PMID:
31197252
15.

Low-Resistance, Concentric-Gated Pediatric Artificial Lung for End-Stage Lung Failure.

Thompson AJ, Buchan S, Carr B, Poling C, Hayes M, Fernando UP, Kaesler A, Schlanstein P, Hesselmann F, Arens J, Potkay JA, Rojas-Pena A, Bartlett RH, Hirschl RB.

ASAIO J. 2019 Jun 6. doi: 10.1097/MAT.0000000000001018. [Epub ahead of print]

PMID:
31192843
16.

Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.

Wu NC, Lv H, Thompson AJ, Wu DC, Ng WWS, Kadam RU, Lin CW, Nycholat CM, McBride R, Liang W, Paulson JC, Mok CKP, Wilson IA.

Cell Host Microbe. 2019 Jun 12;25(6):836-844.e5. doi: 10.1016/j.chom.2019.04.013. Epub 2019 May 28.

17.

Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.

Williams B, Howell J, Doyle J, Thompson AJ, Draper B, Layton C, Latham N, Bramwell F, Membrey D, Mcpherson M, Roney J, Stoové M, Hellard ME, Pedrana A.

Int J Drug Policy. 2019 Oct;72:91-98. doi: 10.1016/j.drugpo.2019.05.012. Epub 2019 May 22.

PMID:
31129023
18.

Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.

Lawitz E, Gane E, Feld JJ, Buti M, Foster GR, Rabinovitz M, Burnevich E, Katchman H, Tomasiewicz K, Lahser F, Jackson B, Shaughnessy M, Klopfer S, Yeh WW, Robertson MN, Hanna GJ, Barr E, Platt HL; C-BREEZE-2 Study Investigators.

J Viral Hepat. 2019 Sep;26(9):1127-1138. doi: 10.1111/jvh.13132. Epub 2019 Jul 11.

PMID:
31108015
19.

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement.

Doyle J, Raggatt M, Slavin M, McLachlan SA, Strasser SI, Sasadeusz JJ, Howell J, Hajkowicz K, Nandurkar H, Johnston A, Bak N, Thompson AJ.

Med J Aust. 2019 Jun;210(10):462-468. doi: 10.5694/mja2.50160. Epub 2019 May 19.

PMID:
31104328
20.

Lameness and lying behavior in grazing dairy cows.

Thompson AJ, Weary DM, Bran JA, Daros RR, Hötzel MJ, von Keyserlingk MAG.

J Dairy Sci. 2019 Jul;102(7):6373-6382. doi: 10.3168/jds.2018-15717. Epub 2019 May 10.

PMID:
31079902
21.

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis.

Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):11020-11027. doi: 10.1073/pnas.1818978116. Epub 2019 May 9.

22.

Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review.

Fehily SR, Papaluca T, Thompson AJ.

Semin Liver Dis. 2019 Jul;39(3):341-353. doi: 10.1055/s-0039-1685538. Epub 2019 Apr 30.

PMID:
31041785
23.

Estimating Joint Health Condition Utility Values.

Thompson AJ, Sutton M, Payne K.

Value Health. 2019 Apr;22(4):482-490. doi: 10.1016/j.jval.2018.09.2843. Epub 2019 Feb 22.

PMID:
30975400
24.

Scale-up of hepatitis C treatment in prisons is key to national elimination.

Papaluca T, Hellard ME, Thompson AJV, Lloyd AR.

Med J Aust. 2019 May;210(9):391-393.e1. doi: 10.5694/mja2.50140. Epub 2019 Apr 9. No abstract available.

PMID:
30968417
25.

Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.

Doyle JS, Scott N, Sacks-Davis R, Pedrana AE, Thompson AJ, Hellard ME; Eliminate Hepatitis C Partnership.

Aliment Pharmacol Ther. 2019 May;49(9):1223-1229. doi: 10.1111/apt.15210. Epub 2019 Mar 25.

PMID:
30908706
26.

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.

Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C.

Antivir Ther. 2019;24(2):133-140. doi: 10.3851/IMP3304.

PMID:
30865588
27.

Virus recognition of glycan receptors.

Thompson AJ, de Vries RP, Paulson JC.

Curr Opin Virol. 2019 Feb;34:117-129. doi: 10.1016/j.coviro.2019.01.004. Epub 2019 Mar 5. Review.

PMID:
30849709
28.

Fructans redistribution prior to sprouting in stored onion bulbs is a potential marker for dormancy break.

Ohanenye IC, Alamar MC, Thompson AJ, Terry LA.

Postharvest Biol Technol. 2019 Mar;149:221-234. doi: 10.1016/j.postharvbio.2018.12.002.

29.

Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs.

Latham NH, Pedrana A, Doyle JS, Howell J, Williams B, Higgs P, Thompson AJ, Hellard ME.

J Viral Hepat. 2019 Jul;26(7):919-922. doi: 10.1111/jvh.13087. Epub 2019 Apr 1.

PMID:
30801881
30.

Clinical relevance of cortical network dynamics in early primary progressive MS.

Tur C, Kanber B, Eshaghi A, Altmann DR, Khaleeli Z, Prados F, Ourselin S, Thompson AJ, Gandini Wheeler-Kingshott CA, Toosy AT, Ciccarelli O.

Mult Scler. 2019 Feb 25:1352458519831400. doi: 10.1177/1352458519831400. [Epub ahead of print]

31.

MSJ 2019 - Editorial comment.

Thompson AJ, Antel J, Carroll WB, Geurts J.

Mult Scler. 2019 Jan;25(1):4-5. doi: 10.1177/1352458518819096. No abstract available.

PMID:
30799696
32.

Learning from a failure in threat assessment: 11 questions and not enough answers.

Goodrum S, Evans MK, Thompson AJ, Woodward W.

Behav Sci Law. 2019 Jul;37(4):353-371. doi: 10.1002/bsl.2399. Epub 2019 Feb 14.

PMID:
30761600
33.

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.

Green CA, Sande CJ, Scarselli E, Capone S, Vitelli A, Nicosia A, Silva-Reyes L, Thompson AJ, de Lara CM, Taylor KS, Haworth K, Hutchings CL, Cargill T, Angus B, Klenerman P, Pollard AJ.

J Infect. 2019 May;78(5):382-392. doi: 10.1016/j.jinf.2019.02.003. Epub 2019 Feb 8.

PMID:
30742894
34.

Rapid changes in tissue mechanics regulate cell behaviour in the developing embryonic brain.

Thompson AJ, Pillai EK, Dimov IB, Foster SK, Holt CE, Franze K.

Elife. 2019 Jan 15;8. pii: e39356. doi: 10.7554/eLife.39356.

35.

Flexibility In Vitro of Amino Acid 226 in the Receptor-Binding Site of an H9 Subtype Influenza A Virus and Its Effect In Vivo on Virus Replication, Tropism, and Transmission.

Obadan AO, Santos J, Ferreri L, Thompson AJ, Carnaccini S, Geiger G, Gonzalez Reiche AS, Rajão DS, Paulson JC, Perez DR.

J Virol. 2019 Mar 5;93(6). pii: e02011-18. doi: 10.1128/JVI.02011-18. Print 2019 Mar 15.

36.

Structural network disruption markers explain disability in multiple sclerosis.

Charalambous T, Tur C, Prados F, Kanber B, Chard DT, Ourselin S, Clayden JD, A M Gandini Wheeler-Kingshott C, Thompson AJ, Toosy AT.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):219-226. doi: 10.1136/jnnp-2018-318440. Epub 2018 Nov 22.

37.

Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease.

Khera AJ, Chase JW, Salzberg M, Thompson AJV, Kamm MA.

Inflamm Bowel Dis. 2019 Feb 21;25(3):620-626. doi: 10.1093/ibd/izy344.

PMID:
30452638
38.

A member of the TERMINAL FLOWER 1/CENTRORADIALIS gene family controls sprout growth in potato tubers.

Morris WL, Alamar MC, Lopez-Cobollo RM, Castillo Cañete J, Bennett M, Van der Kaay J, Stevens J, Kumar Sharma S, McLean K, Thompson AJ, Terry LA, Turnbull CGN, Bryan GJ, Taylor MA.

J Exp Bot. 2019 Feb 5;70(3):835-843. doi: 10.1093/jxb/ery387.

39.

Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.

Santos JJS, Abente EJ, Obadan AO, Thompson AJ, Ferreri L, Geiger G, Gonzalez-Reiche AS, Lewis NS, Burke DF, Rajão DS, Paulson JC, Vincent AL, Perez DR.

J Virol. 2019 Jan 4;93(2). pii: e01413-18. doi: 10.1128/JVI.01413-18. Print 2019 Jan 15.

40.

Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients.

Asgari S, Chaturvedi N, Scepanovic P, Hammer C, Semmo N, Giostra E, Müllhaupt B, Angus P, Thompson AJ, Moradpour D, Fellay J.

J Viral Hepat. 2019 Feb;26(2):271-277. doi: 10.1111/jvh.13019. Epub 2018 Nov 6.

PMID:
30315682
41.

Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.

Hong TP, Gow PJ, Fink M, Dev A, Roberts SK, Nicoll A, Lubel JS, Kronborg I, Arachchi N, Ryan M, Kemp WW, Knight V, Sundararajan V, Desmond P, Thompson AJ, Bell SJ.

Med J Aust. 2018 Oct 15;209(8):348-354.

PMID:
30309301
42.

"B in IT" - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool.

O'Leary DA, Cropp E, Isaac D, Desmond PV, Bell S, Nguyen T, Wong D, Howell J, Richmond J, O'Neill J, Thompson AJ.

Hepatol Med Policy. 2018 Jan 4;3:1. doi: 10.1186/s41124-017-0031-2. eCollection 2018.

43.

Patient-centred care for cirrhosis: a key role for chronic disease management.

Papaluca T, Thompson AJ.

Med J Aust. 2018 Sep 1;209(7):296-297. No abstract available.

PMID:
30257630
44.

Avenues to Characterize the Interactions of Extended N-Glycans with Proteins by NMR Spectroscopy: The Influenza Hemagglutinin Case.

Fernández de Toro B, Peng W, Thompson AJ, Domínguez G, Cañada FJ, Pérez-Castells J, Paulson JC, Jiménez-Barbero J, Canales Á.

Angew Chem Int Ed Engl. 2018 Nov 12;57(46):15051-15055. doi: 10.1002/anie.201807162. Epub 2018 Oct 17.

45.

Proximity Ligation-Based Fluorogenic Imaging Agents for Neuraminidases.

Gao Z, Thompson AJ, Paulson JC, Withers SG.

Angew Chem Int Ed Engl. 2018 Oct 8;57(41):13538-13541. doi: 10.1002/anie.201808196. Epub 2018 Sep 14.

46.

NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Mayo MJ, Wigg AJ, Leggett BA, Arnold H, Thompson AJ, Weltman M, Carey EJ, Muir AJ, Ling L, Rossi SJ, DePaoli AM.

Hepatol Commun. 2018 Aug 30;2(9):1037-1050. doi: 10.1002/hep4.1209. eCollection 2018 Sep.

47.

Humoral and cellular immunity to RSV in infants, children and adults.

Green CA, Sande CJ, de Lara C, Thompson AJ, Silva-Reyes L, Napolitano F, Pierantoni A, Capone S, Vitelli A, Klenerman P, Pollard AJ.

Vaccine. 2018 Oct 1;36(41):6183-6190. doi: 10.1016/j.vaccine.2018.08.056. Epub 2018 Aug 31.

PMID:
30177258
48.

Quantitative MRI of rostral spinal cord and brain regions is predictive of functional recovery in acute spinal cord injury.

Seif M, Curt A, Thompson AJ, Grabher P, Weiskopf N, Freund P.

Neuroimage Clin. 2018 Aug 19;20:556-563. doi: 10.1016/j.nicl.2018.08.026. eCollection 2018.

49.

Mapping the Orthosteric Binding Site of the Human 5-HT3 Receptor Using Photo-cross-linking Antagonists.

Jack T, Leuenberger M, Ruepp MD, Vernekar SKV, Thompson AJ, Braga-Lagache S, Heller M, Lochner M.

ACS Chem Neurosci. 2019 Jan 16;10(1):438-450. doi: 10.1021/acschemneuro.8b00327. Epub 2018 Sep 11.

PMID:
30149702
50.

Design Analysis and Optimization of a Single-Layer PDMS Microfluidic Artificial Lung.

Thompson AJ, Ma LJ, Plegue TJ, Potkay JA.

IEEE Trans Biomed Eng. 2019 Apr;66(4):1082-1093. doi: 10.1109/TBME.2018.2866782. Epub 2018 Aug 22.

PMID:
30139043

Supplemental Content

Loading ...
Support Center